Overall, our results suggest that the XO inhibitor allopurinol might have a protective effect against periodontitis-mediated CVD by blocking the increase of ROS generation mediated by XO and NOX4 in PG-LPS-treated mice. Here, NOX4 is linked to periodontitis.